Focus
immunotherapy
Common Immunotherapy Could Treat Heart Failure, Animal Study Finds
Scientists target scar tissue formation in a new heart failure treatment approach.
New Immunotherapy Boosts Hodgkin Lymphoma Survival Rate to 92 Percent
The treatment also showed a reduction in long-term side effects.
New Immunotherapy Shows Promise in Fighting Colon Cancer
NIH researchers achieve tumor shrinkage with new immunotherapy using engineered cells.
FDA Approves 1st T-Cell Therapy for Melanoma
The therapy was granted accelerated approval for its use in treating patients with metastatic and unremovable melanoma.
Cancer Patients With Mutated Mitochondria Respond Better to Treatment
Mutated mitochondrial DNA is common among cancer patients, and luckily, it may provide a way to bolster treatment.
